Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine

NCT01592747 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

479

Enrollment

INDUSTRY

Sponsor class

Conditions

Autistic Disorder
Autism
Asperger's Disorder
Asperger Syndrome
Autism Spectrum Disorders
Pervasive Developmental Disorder - Not Otherwise Specified (PDD-NOS)

Interventions

DRUG: Memantine Hydrochloride (HCl)
DRUG: Memantine Hydrochloride (HCl)
DRUG: Placebo capsules

Sponsor

Forest Laboratories